These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31970591)

  • 1. Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies.
    Knott MML; Hölting TLB; Ohmura S; Kirchner T; Cidre-Aranaz F; Grünewald TGP
    Cancer Metastasis Rev; 2019 Dec; 38(4):625-642. PubMed ID: 31970591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma.
    Hölting TLB; Cidre-Aranaz F; Matzek D; Popper B; Jacobi SJ; Funk CM; Geyer FH; Li J; Piseddu I; Cadilha BL; Ledderose S; Zwilling J; Ohmura S; Anz D; Künkele A; Klauschen F; Grünewald TGP; Knott MML
    Mol Cancer; 2022 Oct; 21(1):199. PubMed ID: 36229873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of IGF2, Hedgehog and fusion gene expression profiles in pediatric sarcomas.
    de Souza RR; Oliveira ID; del Giúdice Paniago M; Yaoita FH; Caran EM; Macedo CR; Petrilli AS; Abib Sde C; de Seixas Alves MT; de Toledo SR
    Growth Horm IGF Res; 2014 Aug; 24(4):130-6. PubMed ID: 24846856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas.
    Lanzi C; Cassinelli G
    Biochem Pharmacol; 2022 Apr; 198():114944. PubMed ID: 35152144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
    Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional genomics of Ewing sarcoma].
    Grünewald TGP
    Pathologe; 2017 Nov; 38(Suppl 2):198-201. PubMed ID: 28849372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 is an oncogenic mediator in Ewing Sarcoma.
    Christensen L; Joo J; Lee S; Wai D; Triche TJ; May WA
    PLoS One; 2013; 8(1):e54556. PubMed ID: 23365673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.
    Specht K; Sung YS; Zhang L; Richter GH; Fletcher CD; Antonescu CR
    Genes Chromosomes Cancer; 2014 Jul; 53(7):622-33. PubMed ID: 24723486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma.
    Seong BKA; Dharia NV; Lin S; Donovan KA; Chong S; Robichaud A; Conway A; Hamze A; Ross L; Alexe G; Adane B; Nabet B; Ferguson FM; Stolte B; Wang EJ; Sun J; Darzacq X; Piccioni F; Gray NS; Fischer ES; Stegmaier K
    Cancer Cell; 2021 Sep; 39(9):1262-1278.e7. PubMed ID: 34329586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
    He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
    Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWSR1 fusion proteins mediate PAX7 expression in Ewing sarcoma.
    Charville GW; Wang WL; Ingram DR; Roy A; Thomas D; Patel RM; Hornick JL; van de Rijn M; Lazar AJ
    Mod Pathol; 2017 Sep; 30(9):1312-1320. PubMed ID: 28643791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma.
    Yasir M; Park J; Chun W
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Integrative molecular pathology of cancer].
    Grünewald TGP
    Pathologe; 2020 Dec; 41(Suppl 2):67-69. PubMed ID: 33263807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy.
    Kovar H
    Expert Opin Ther Targets; 2014 Nov; 18(11):1315-28. PubMed ID: 25162919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Round Blue Cell Sarcoma Other Than Ewing Sarcoma: What Should an Oncologist Know?
    Davis JL; Rudzinski ER
    Curr Treat Options Oncol; 2020 Sep; 21(11):90. PubMed ID: 32875423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
    Hung YP; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma.
    Wang WL; Patel NR; Caragea M; Hogendoorn PC; López-Terrada D; Hornick JL; Lazar AJ
    Mod Pathol; 2012 Oct; 25(10):1378-83. PubMed ID: 22766791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease.
    Kovar H; Amatruda J; Brunet E; Burdach S; Cidre-Aranaz F; de Alava E; Dirksen U; van der Ent W; Grohar P; Grünewald TG; Helman L; Houghton P; Iljin K; Korsching E; Ladanyi M; Lawlor E; Lessnick S; Ludwig J; Meltzer P; Metzler M; Mora J; Moriggl R; Nakamura T; Papamarkou T; Radic Sarikas B; Rédini F; Richter GH; Rossig C; Schadler K; Schäfer BW; Scotlandi K; Sheffield NC; Shelat A; Snaar-Jagalska E; Sorensen P; Stegmaier K; Stewart E; Sweet-Cordero A; Szuhai K; Tirado OM; Tirode F; Toretsky J; Tsafou K; Üren A; Zinovyev A; Delattre O
    Oncotarget; 2016 Feb; 7(8):8613-24. PubMed ID: 26802024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma.
    Knezevich SR; Hendson G; Mathers JA; Carpenter B; Lopez-Terrada D; Brown KL; Sorensen PH
    Hum Pathol; 1998 Mar; 29(3):289-94. PubMed ID: 9496833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.